company

PHARMA HOLDING INNHERRED AS

7604 LEVANGER

Return on Equity
41,34 %
Current Ratio
3,09
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue92 000
Net Income449 000
Total Assets1 294 000
Total Equity1 086 000
Income (NOK)2022
Revenue92 000
Expenditure69 000
Operating Profit23 000
Financial Income436 000
Financial Costs1 000
Financial Balance435 000
Earnings Before Tax457 000
Tax8 000
Net Income449 000
Balance (NOK)2022
Total Fixed Assets652 000
Total Current Assets643 000
Total Assets1 294 000
Total Retained Equity906 000
Total Equity1 086 000
Total Long-Term Debt0
Total Current Debt208 000
Total Equity and Debt1 294 000
Cash flow (NOK)2022
Sales Income92 000
Other Income0
Revenue92 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure69 000
Operating Profit23 000
Financial Income436 000
Financial Costs1 000
Financial Balance435 000
Dividends200 000
Net Income449 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets652 000
Total Fixed Assets652 000
Stock0
Total Investments0
Cash, Bank627 000
Total Current Assets643 000
Total Assets1 294 000
Total Equity1 086 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends200 000
Other Current Debt0
Total Current Debt208 000
Total Equity and Debt1 294 000
Financial indicators2022
Return on Equity41,34 %
Debt-to-Equity Ratio0
Operating Profit Margin25 %
Current Ratio3,09
Quick Ratio3,09
Equity Ratio0,84
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English